Skip to content

Achromobacter Spp: Description of Epidemiology and Resistance in Chronic Ear Infections and in Healthy Individuals.

Achromobacter Spp: Description of Epidemiology and Resistance in Chronic Ear Infections and in Healthy Individuals.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04483232
Acronym
AERIO
Enrollment
1800
Registered
2020-07-23
Start date
2020-08-31
Completion date
2020-08-31
Last updated
2020-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achromobacter, Chronic Ear Infection, Epidemiology

Brief summary

Hearing loss can be the result of chronic ear infections. The role of bacteria of the genus Achromobacter is not known in these conditions. An epidemiological study including a large number of patients is needed to compare the prevalence of these bacteria in sick and healthy subjects, and to highlight the characteristics of the strains and the factors favouring their emergence.

Interventions

BIOLOGICALEar canal swab

Ear canal swab

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Person or parent who has given his or her non-opposition * Person over 10 years of age * Sick Subjects Group : diagnosis of chronic infection by an ENT specialist doctor if patient already included: new episode \> 3 months after the complete clinical recovery from the previous episode observed by the ENT doctor - Healthy group: no ear infection in the last 6 months and no antibiotics in the previous month.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Achromobacter positive sample numberThrough study completion, an average of 3 years

Countries

France

Contacts

Primary ContactLucie AMOUREUX
lucie.amoureux@chu-dijon.fr03.80.29.56.86

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026